Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001858612 | SCV002247231 | pathogenic | not provided | 2024-11-27 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg187*) in the RAB3GAP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RAB3GAP1 are known to be pathogenic (PMID: 23420520). This variant is present in population databases (rs764260054, gnomAD 0.007%). This premature translational stop signal has been observed in individual(s) with clinical features of Warburg micro syndrome (PMID: 28454995, 29878067). ClinVar contains an entry for this variant (Variation ID: 800891). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV001858612 | SCV003805282 | pathogenic | not provided | 2022-08-15 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28454995, 29878067) |
Genomic Medicine Center of Excellence, |
RCV000985081 | SCV004805023 | pathogenic | Warburg micro syndrome 1 | 2024-03-17 | criteria provided, single submitter | research | |
Biochemical Molecular Genetic Laboratory, |
RCV000985081 | SCV001133041 | likely pathogenic | Warburg micro syndrome 1 | 2019-09-26 | no assertion criteria provided | clinical testing |